Grants for City or township governments - Consumer Protection

This funding opportunity provides $1 million to various organizations to develop and implement strategies for effectively sharing clinical practice guidelines, particularly in underserved communities, to improve healthcare quality and equity.

This funding opportunity is designed to support collaborations between the FDA and the generic drug industry to advance research and development of complex generic medications, ultimately improving patient access to safe and effective drugs.

This funding opportunity provides financial support to state and local governments, tribal entities, and accredited educational institutions to enhance their food testing laboratories' capabilities and improve national food safety through advanced testing and emergency response initiatives.

This funding opportunity provides financial support to various organizations, including universities and non-profits, to improve veterinary diagnostic capabilities and address public health issues related to animal food safety and antimicrobial resistance.

This funding opportunity supports a variety of organizations in conducting innovative research to develop medical products for preventing, diagnosing, and treating ALS and other rare neurodegenerative diseases.

This funding opportunity provides up to $1 million for various organizations to develop innovative projects that improve diversity and inclusivity in clinical trials, enhance data on underrepresented groups, and capture diverse patient perspectives to promote health equity.

This funding opportunity provides $250,000 to various organizations to develop educational programs that raise awareness about the health risks of skin lightening products and promote safer alternatives in communities.

This funding opportunity provides financial support for clinical trials aimed at developing new treatments for rare neurodegenerative diseases, targeting a wide range of eligible applicants including universities, nonprofits, and government entities.

This grant provides funding to various organizations, including governments and educational institutions, to promote research and initiatives that improve health equity for racial and ethnic minority populations.

This funding opportunity supports clinical trials aimed at developing new therapies for rare neurodegenerative diseases, such as ALS, and is open to a wide range of eligible organizations, including universities and nonprofits.

This funding opportunity provides $2 million to a variety of organizations for research projects focused on improving pain management, anesthesia safety, and addiction treatment strategies.

The Food Security Infrastructure Grant (FSIG) Program seeks to ensure that farmers, commercial fishermen, and other local food producers are better engaged with a strong, resilient food system to help mitigate food supply and distribution disruptions, as well as to ensure that individuals and families throughout the Commonwealth have equitable access to food, with a focus on food that is produced locally. Donor Name: Massachusetts Department of Agricultural Resources State: Massachusetts County: All Counties Type of Grant: Grant Deadline: 05/02/2024 Size of the Grant: $100,000 to $500,000 Grant Duration: 1 Year Details: Projects to enhance equitable access to food for individuals and families throughout the Commonwealth, with a focus on food that is produced locally. The FSIG program (“Program”) also seeks to ensure that farmers, fisherman, and other local food producers are better connected to markets in a strong, resilient food system, and that they have the infrastructure needed to produce and distribute healthy food efficiently and safely. Providing greater, more equitable access to local food and strengthening the role of local food in the Commonwealth’s food system is an important goal of the Program. Local food is defined through this Program as food which is grown/produced and distributed within the Commonwealth. The local food system is a network of consumers, workers, businesses, owners, and supporting organizations engaged in an array of activities, including fishing, farming, preparing, marketing, distributing, serving, and eating food. This network works to produce and distribute food that nourishes the communities, sustains businesses and workers, and supports responsible stewardship of the land, water, and other natural resources. Funding Information Part I: Agriculture Maximum funding per applicant $500,000. Part II: Local Food System Maximum funding per applicant $500,000. Grant Period July 1, 2024 to June 30, 2025. Eligible Projects  Eligible projects must be capital improvements including the purchase of equipment and contracted labor costs in order to implement projects, or costs associated with planning and design directly related to capital projects that will allow applicants to strengthen and improve the resiliency of the Commonwealth’s food system while allowing greater access to fresh, local food in a way that addresses systemic inequities. Eligibility Criteria  Applicants may be individuals, for-profit, or non-profit entities. Municipalities and other governmental entities may also be eligible to apply, provided all necessary requirements to submit an application can be met, the ability to utilize funding can be demonstrated, and the entity has the ability to enter into a contract with MDAR. For more information, visit MDAR.

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

The Pool Safely Grant Program funding opportunity assists states, local governments, and Native American Tribal Governments in implementing enforcement and education programs to prevent the drowning and drain entrapment of children in pools and spas.

The purpose of the SG Program is to assist agencies of the State of California address cybersecurity risks and threats to information systems, and improve security of critical infrastructure and resilience of the services these entities provide to their communities.

AmeriCorps improves lives, strengthens communities, and fosters civic engagement through service and volunteering. AmeriCorps brings people together to tackle some of the countrys most pressing challenges through national service and volunteerism. AmeriCorps members and AmeriCorps Seniors volunteers serve with organizations dedicated to the improvement of communities and those serving. AmeriCorps helps make service a cornerstone of our national culture. This funding announcement is an opportunity for communities to apply for funding to engage adults ages 55 and older in tackling the communitys most pressing needs through the AmeriCorps Seniors RSVP program. This is an open competition across all states and territories.

This funding opportunity supports U.S.-based organizations in conducting research to better understand and manage heart-related side effects of cancer treatments, with a focus on improving detection, monitoring, and data sharing.

This program provides financial assistance to small business and commercial property owners in Jackson, Mississippi, to improve the appearance of their buildings and attract more customers and investors.

The purpose of this FOA is to develop and maintain Rapid Response Teams (RRTs) to facilitate long-term improvements and innovation to the national integrated food safety system by unifying and coordinating federal/state/local human and animal food (HAF) emergency response efforts including:1) Strengthening the link among epidemiology, lab and environmental health/regulatory components;2) Improving States' regulatory and surveillance HAF protection programs to include using Incident Command System (ICS)/National Incident Management System (NIMS) principles and a Unified Command structure to conduct integrated responses to all-hazards HAF emergencies, rapidly identifying and removing tainted food from commerce, and conducting root cause investigations to inform future prevention efforts; and3) Addressing supporting components, such as training, data sharing, data analysis, communications, continuous process improvement, and development of best practices and other resources to support national response capacity/capability development.

The purpose of this funding opportunity announcement (FOA) is to support efficient natural history studies alone or in conjunction with the development and validation of clinical outcome assessments (COAs) and/or biomarker studies to address the unmet needs in rare neurodegenerative diseases for children and adults. Through the support of studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare neurodegenerative disease or multiple rare neurodegenerative diseases with similar pathophysiology, and facilitate rare disease product development.